Senile osteoporosis (SOP), also known as degenerative osteoporosis, a special performance of biological aging in bone are the occurrence of osteoporosis type Ⅱ, it is growing with age, bone mineral composition and reducing the proportion of bone matrix. Bone thinning, the reduction in the number of bone small beam. A systemic metabolic disorder of increased bone fragility and risk of fracture increased degenerative diseases. It is the increase in bone fragility and lead to fracture increases the risk of a common disease. Women generally in postmenopausal more than 20 years. Male age around 70 years of age or more, the incidence of female-male 2 times. Type trabecular and cortical bone, bone loss with age-related bone loss. Began 40 to 50-year-old men and women with age-related bone loss in the spine, gender rate of bone loss similar to the limbs lost 0.3% to 0.6% annually, spine lost 0.8% to 1.2% annually. Fractures occur in the spine and hip.

Human Hydroxylysine glycosides (HOLG) ELISA Kit employs a two-site sandwich ELISA to quantitate HOLG in samples. An antibody specific for HOLG has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and anyHOLG present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for HOLG is added to the wells. After washing, Streptavidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of HOLG bound in the initial step. The color development is stopped and the intensity of the color is measured.

Human Hydroxylysine glycosides (HOLG) ELISA Kit listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Find more details at http://www.abbkine.com/product/human-hydroxylysine-glycosides-holg-elisa-kit-kte62529/

Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Combining cutting edge technology from United States with China's manufacturing engineering and cost advantages, we aim to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, etc.